Loading clinical trials...
Loading clinical trials...
Clinical Usefulness of Combining Biomarkers (AFP, AFP-L3, and PIVKA-II) With Abdominal Sonography or Computed Tomography for Early Detection of Hepatocellular Carcinoma
Conditions
Interventions
AFP-L3
AFP
+3 more
Locations
15
South Korea
Korea University Ansan Hospital
Ansan, Gyeonggi-do, South Korea
The Catholic University of Korea Uijeongbu St.Mary's Hospital
Uijeongbu-si, Gyeonggi-do, South Korea
Keimyung University Dongsan Medical Center
Daegu, South Korea
Inje University SangGye Paik Hospital
Seoul, South Korea
Korea University Anam Hospital
Seoul, South Korea
Seoul National University Hospital
Seoul, South Korea
Start Date
July 1, 2016
Primary Completion Date
June 30, 2023
Completion Date
February 28, 2026
Last Updated
June 4, 2020
NCT07175441
NCT07439939
NCT05969860
NCT06427941
NCT05842174
NCT07164313
Lead Sponsor
Korea University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions